Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 3 (1)

Trial Status

Unknown2
Not Yet Recruiting2
Withdrawn1
Recruiting1

Clinical Trials (6)

Showing 6 of 6 trials
NCT07739641Not ApplicableNot Yet RecruitingPrimary

A COMPARATIVE STUDY BETWEEN OPIOID-FREE GENERAL ANAESTHESIA AND OPIOID-BASED GENERAL ANAESTHESIA ON THE QUALITY OF RECOVERY IN PATIENTS UNDERGOING ELECTIVE LAPAROSCOPIC HYSTRECTOMY: A Randomized Trial

NCT07414706Phase 3Not Yet Recruiting

Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery

NCT07044440Not ApplicableRecruiting

Digital Follow-up Program After Discharge Home Following Thoracic Surgery

NCT05081232Not ApplicableWithdrawnPrimary

Continence and Potency Following Multi-Layer Perinatal Issue alloGraft

NCT04863651Unknown

Attachment Predicts Post Cesarean Pain

NCT03680391UnknownPrimary

Effect of Early Posroperative Feeding on Gastrointestinal Function After Cesarean Section

Showing all 6 trials

Research Network

Activity Timeline